Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	SNARE binding	UNC13B VPS50 RNF40 VPS54 ADCY6 NBAS VAMP7	7.31e-05	136	149	7	GO:0000149
HumanPheno	Perifollicular hyperkeratosis	KRT81 KRT83 KRT86	6.16e-06	4	60	3	HP:0007468
HumanPheno	Abnormal perifollicular morphology	KRT81 KRT83 KRT86	3.03e-05	6	60	3	HP:0031285
MousePheno	increased circulating LDL cholesterol level	CT45A6 CT45A1 CT45A10 CT45A2 APOB CT45A7 CT45A9 CT45A3	7.45e-07	80	130	8	MP:0000182
Domain	INT_SG_DDX_CT_C	CT45A1 CT45A10 CT45A7 CT45A9 CT45A3	1.60e-09	8	148	5	PF15300
Domain	INT_SG_DDX_CT_C	CT45A1 CT45A10 CT45A7 CT45A9 CT45A3	1.60e-09	8	148	5	IPR029307
Domain	Vps54_N	VPS50 VPS54	6.24e-05	2	148	2	PF10475
Domain	Sec15	EXOC6 EXOC6B	6.24e-05	2	148	2	PF04091
Domain	EXOC6/Sec15	EXOC6 EXOC6B	6.24e-05	2	148	2	IPR007225
Domain	VPS54_N	VPS50 VPS54	6.24e-05	2	148	2	IPR019515
Domain	GYF	GIGYF1 GIGYF2	1.86e-04	3	148	2	PS50829
Domain	PAH	SIN3B GON4L	1.86e-04	3	148	2	IPR003822
Domain	-	SIN3B GON4L	1.86e-04	3	148	2	1.20.1160.11
Domain	PAH	SIN3B GON4L	1.86e-04	3	148	2	PS51477
Domain	Heat_shock_protein_90_CS	HSP90B1 HSP90AB1	1.86e-04	3	148	2	IPR019805
Domain	GYF	GIGYF1 GIGYF2	1.86e-04	3	148	2	SM00444
Domain	Relaxin	RLN1 RLN2	1.86e-04	3	148	2	IPR022421
Domain	GYF	GIGYF1 GIGYF2	1.86e-04	3	148	2	PF02213
Domain	PAH	SIN3B GON4L	1.86e-04	3	148	2	PF02671
Domain	-	GIGYF1 GIGYF2	1.86e-04	3	148	2	3.30.1490.40
Domain	-	TMPRSS11D AGRN TMPRSS11A	2.07e-04	15	148	3	3.30.70.960
Domain	-	NET1 ARHGEF38 ARHGEF12 ALS2CL ARHGEF4	2.50e-04	71	148	5	1.20.900.10
Domain	DH-domain	NET1 ARHGEF38 ARHGEF12 ALS2CL ARHGEF4	2.50e-04	71	148	5	IPR000219
Domain	RmlC_Cupin	CT45A1 CT45A2 CT45A3	2.53e-04	16	148	3	IPR011051
Domain	Hsp90_fam	HSP90B1 HSP90AB1	3.70e-04	4	148	2	IPR001404
Domain	Hsp90_N	HSP90B1 HSP90AB1	3.70e-04	4	148	2	IPR020575
Domain	HSP90	HSP90B1 HSP90AB1	3.70e-04	4	148	2	PF00183
Domain	HSP90	HSP90B1 HSP90AB1	3.70e-04	4	148	2	PS00298
Domain	GYF	GIGYF1 GIGYF2	3.70e-04	4	148	2	IPR003169
Domain	Pept_S1A_HAT/DESC1	TMPRSS11D TMPRSS11A	6.14e-04	5	148	2	IPR017329
Domain	Kazal_1	SMOC2 AGRN SPINK5	6.72e-04	22	148	3	PF00050
Domain	SEA	TMPRSS11D AGRN TMPRSS11A	6.72e-04	22	148	3	PF01390
Domain	SEA	TMPRSS11D AGRN TMPRSS11A	7.69e-04	23	148	3	PS50024
Domain	SEA_dom	TMPRSS11D AGRN TMPRSS11A	7.69e-04	23	148	3	IPR000082
Domain	Keratin_2_head	KRT81 KRT83 KRT86	8.73e-04	24	148	3	IPR032444
Domain	Keratin_2_head	KRT81 KRT83 KRT86	8.73e-04	24	148	3	PF16208
Domain	Insulin_family	RLN1 RLN2	9.16e-04	6	148	2	IPR022352
Domain	Keratin_II	KRT81 KRT83 KRT86	1.11e-03	26	148	3	IPR003054
Domain	DH_1	NET1 ARHGEF38 ARHGEF12 ARHGEF4	1.57e-03	63	148	4	PS00741
Domain	AC_N	ADCY3 ADCY6	1.69e-03	8	148	2	IPR032628
Domain	Adcy	ADCY3 ADCY6	1.69e-03	8	148	2	IPR030672
Domain	AC_N	ADCY3 ADCY6	1.69e-03	8	148	2	PF16214
Domain	SH3	ABL2 ARHGEF38 SORBS3 DLG4 ARHGEF4 PALS2 FYB2	1.70e-03	216	148	7	SM00326
Domain	SH3_domain	ABL2 ARHGEF38 SORBS3 DLG4 ARHGEF4 PALS2 FYB2	1.88e-03	220	148	7	IPR001452
Domain	RhoGEF	NET1 ARHGEF38 ARHGEF12 ARHGEF4	2.08e-03	68	148	4	SM00325
Domain	Insulin_CS	RLN1 RLN2	2.16e-03	9	148	2	IPR022353
Domain	Acyl-CoA_DH_CS	ACADL ACADM	2.16e-03	9	148	2	IPR006089
Domain	-	RLN1 RLN2	2.16e-03	9	148	2	1.10.100.10
Domain	RhoGEF	NET1 ARHGEF38 ARHGEF12 ARHGEF4	2.31e-03	70	148	4	PF00621
Domain	DH_2	NET1 ARHGEF38 ARHGEF12 ARHGEF4	2.31e-03	70	148	4	PS50010
Domain	INSULIN	RLN1 RLN2	2.69e-03	10	148	2	PS00262
Domain	ACYL_COA_DH_1	ACADL ACADM	2.69e-03	10	148	2	PS00072
Domain	ACYL_COA_DH_2	ACADL ACADM	2.69e-03	10	148	2	PS00073
Domain	Insulin	RLN1 RLN2	2.69e-03	10	148	2	PF00049
Domain	Kazal_2	SMOC2 AGRN SPINK5	2.87e-03	36	148	3	PF07648
Domain	Insulin	RLN1 RLN2	3.27e-03	11	148	2	IPR004825
Domain	Acyl-CoA_dh_N	ACADL ACADM	3.27e-03	11	148	2	PF02771
Domain	Insulin-like	RLN1 RLN2	3.27e-03	11	148	2	IPR016179
Domain	Laminin_G_1	LAMA1 AGRN	3.27e-03	11	148	2	PF00054
Domain	IlGF	RLN1 RLN2	3.27e-03	11	148	2	SM00078
Domain	LAM_G_DOMAIN	LAMA1 NRXN3 AGRN	3.36e-03	38	148	3	PS50025
Domain	GDS_CDC24_CS	NET1 ARHGEF12 ARHGEF4	3.62e-03	39	148	3	IPR001331
Domain	PROTEIN_KINASE_ATP	CDC42BPG ABL2 BRSK2 CDKL4 STK32C OXSR1 MERTK BRSK1 ULK2 MAST3	3.64e-03	459	148	10	PS00107
Domain	Kinase-like_dom	CDC42BPG ABL2 PDCD6IP BRSK2 CDKL4 STK32C OXSR1 MERTK BRSK1 ULK2 MAST3	3.98e-03	542	148	11	IPR011009
Domain	-	ACADL ACADM	4.59e-03	13	148	2	1.10.540.10
Domain	Acyl-CoA_dh_1	ACADL ACADM	4.59e-03	13	148	2	PF00441
Domain	AcylCoA_DH/ox_N	ACADL ACADM	4.59e-03	13	148	2	IPR013786
Domain	LamG	LAMA1 NRXN3 AGRN	5.09e-03	44	148	3	SM00282
Domain	SEA	TMPRSS11D AGRN	5.33e-03	14	148	2	SM00200
Domain	Prot_kinase_dom	CDC42BPG ABL2 BRSK2 CDKL4 STK32C OXSR1 MERTK BRSK1 ULK2 MAST3	5.65e-03	489	148	10	IPR000719
Domain	KAZAL	SMOC2 AGRN SPINK5	5.77e-03	46	148	3	SM00280
Domain	PROTEIN_KINASE_DOM	CDC42BPG ABL2 BRSK2 CDKL4 STK32C OXSR1 MERTK BRSK1 ULK2 MAST3	5.98e-03	493	148	10	PS50011
Domain	Acyl-CoA_Oxase/DH_cen-dom	ACADL ACADM	6.12e-03	15	148	2	IPR006091
Domain	AcylCoA_DH/oxidase_NM_dom	ACADL ACADM	6.12e-03	15	148	2	IPR009100
Domain	Acyl-CoA_dh_M	ACADL ACADM	6.12e-03	15	148	2	PF02770
Domain	IQ	PCP4 MYO1B IQCD IQGAP3	6.41e-03	93	148	4	PS50096
Domain	-	LAMA1 NRXN3 LMAN2 AGRN	6.90e-03	95	148	4	2.60.120.200
Domain	Guanylate_kinase_CS	DLG4 PALS2	6.96e-03	16	148	2	IPR020590
Domain	AcylCo_DH/oxidase_C	ACADL ACADM	6.96e-03	16	148	2	IPR009075
Domain	KAZAL_2	SMOC2 AGRN SPINK5	7.28e-03	50	148	3	PS51465
Domain	SH3	ABL2 ARHGEF38 SORBS3 DLG4 ARHGEF4 PALS2	7.56e-03	216	148	6	PS50002
Domain	Ser/Thr_kinase_AS	CDC42BPG BRSK2 CDKL4 STK32C OXSR1 BRSK1 ULK2 MAST3	7.68e-03	357	148	8	IPR008271
Domain	Kazal_dom	SMOC2 AGRN SPINK5	7.69e-03	51	148	3	IPR002350
Domain	A/G_cyclase_CS	ADCY3 ADCY6	7.85e-03	17	148	2	IPR018297
Pubmed	Identification of cancer/testis-antigen genes by massively parallel signature sequencing.	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5	2.38e-18	15	153	9	15905330
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	COPA NET1 CALU KRT81 SMC1A INPPL1 KRT86 ANXA5 ARHGEF12 MCM6 NUP214 MCCC1 MFAP1 SLC25A12 FAM13A TPX2 WDR82 ARHGEF4 HSD17B4 PLEKHA7	4.31e-09	916	153	20	32203420
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ABL2 PDCD6IP NET1 CALU INPPL1 BRSK2 GIGYF1 STK32C MCCC1 CEP350 FAM13A ZFP36L2 SYNE2 SSX2IP KIF14 GIGYF2 ARHGEF4 PLEKHA7 RGL2	9.16e-09	861	153	19	36931259
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	HSP90B1 PDCD6IP COPA SLC2A7 SMC1A ANXA5 SMPD4 RNF40 APOB NUP214 ADRA2C SYNE2 TPX2 PRICKLE2 KIF14 IL1RN ZMYM4	4.29e-08	754	153	17	35906200
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ERCC5 SFSWAP COPA SMC1A NUP214 ADCY6 MFAP1 GTF2I FAM13A TPX2 SORBS3 GIGYF2 AFF1 OXSR1 ZMYM4 KDM4B HSP90AB1	6.24e-08	774	153	17	15302935
Pubmed	Novel KRT83 and KRT86 mutations associated with monilethrix.	KRT81 KRT83 KRT86	8.35e-08	3	153	3	25557232
Pubmed	Structure and site of expression of a murine type II hair keratin.	KRT81 KRT83 KRT86	8.35e-08	3	153	3	1372089
Pubmed	Transient expression of mouse hair keratins in transfected HeLa cells: interactions between "hard" and "soft" keratins.	KRT81 KRT83 KRT86	8.35e-08	3	153	3	1712823
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	EXOC6 NET1 DIABLO SMC1A ANXA5 MAEA VPS50 MCM6 GIGYF1 FAAP100 ADCY6 MFAP1 SOWAHA GTF2I ZFP36L2 VAMP7 EXOC6B GIGYF2 PLEKHA7 IQGAP3 FYB2 MAST3	8.65e-08	1321	153	22	27173435
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HSP90B1 PDCD6IP COPA SMC1A KRT86 ANXA5 MYO1B MCM6 NUP214 CEP350 MFAP1 EEF1G SYNE2 KIF14 GIGYF2 LMAN2 HSD17B4 RPL5 HSP90AB1	1.39e-07	1024	153	19	24711643
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	EXOC6 SMC1A INPPL1 ARHGEF12 CEP350 NBAS SYNE2 SSX2IP KIF14 PLEKHA7	1.86e-07	251	153	10	29778605
Pubmed	Keratins of the human hair follicle.	KRT81 KRT83 KRT86	3.33e-07	4	153	3	15797458
Pubmed	Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.	ACADM COPA CALU SMC1A MYO1B MCM6 TPX2 RPL5 IQGAP3	5.15e-07	215	153	9	30462309
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	DNAH3 HSP90B1 PDCD6IP COPA CALU SMC1A KRT86 ANXA5 WNT7B MYO1B MCM6 EEF1G SLC25A12 AGRN RPL5 HSP90AB1	5.70e-07	803	153	16	36517590
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	HSP90B1 PDCD6IP NVL MCM6 NUP214 MCCC1 CEP350 EEF1G GTF2I ZMYM4 HSP90AB1	5.82e-07	357	153	11	37059091
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DIABLO LAMA1 GON4L MYO1B EEF1G GTF2I TPX2 GIGYF2 HSP90AB1	1.04e-06	234	153	9	36243803
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	HSP90B1 SFSWAP CALU SMC1A NVL MYO1B ABT1 SYF2 MFAP1 GTF2I TPX2 GIGYF2 WDR82 HSD17B4 RPL5 ZMYM4	1.14e-06	847	153	16	35850772
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	HSP90B1 PDCD6IP COPA DIABLO CALU SMC1A ANXA5 MYO1B MCM6 APOB NUP214 EEF1G GTF2I KIF14 GIGYF2 LMAN2 HSD17B4 PLEKHA7 RPL5 IQGAP3 HSP90AB1	1.27e-06	1425	153	21	30948266
Pubmed	Laminin alpha1 globular domains 4-5 induce fetal development but are not vital for embryonic basement membrane assembly.	LAMA1 ITGA6 AGRN	1.65e-06	6	153	3	15668394
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	UNC13B ARHGEF12 GON4L R3HDM2 NUP214 ADCY3 ADCY6 MFN2 GIGYF2 ARHGEF4 ULK2	2.08e-06	407	153	11	12693553
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	ABL2 KRT81 KRT83 INPPL1 KRT86 EEF1G GTF2I HSD17B4 HSP90AB1	2.99e-06	266	153	9	19380743
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	HSP90B1 PDCD6IP ACADL COPA ANXA5 MYO1B MCCC1 NBAS EEF1G DUOX1 PALS2 BRSK1 RPL5 IQGAP3 HSP90AB1	3.06e-06	807	153	15	30575818
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	HSP90B1 ABL2 PDCD6IP COPA SMC1A ARHGEF12 MYO1B NUP214 EEF1G GIGYF2 LMAN2 ADGRL2 RPL5 HSP90AB1	3.28e-06	708	153	14	39231216
Pubmed	A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.	APOB NRXN3 LOXHD1 MICAL2 ARHGEF4 PALS2 RPL5 ZMYM4	3.78e-06	205	153	8	12040188
Pubmed	CIN85 interacting proteins in B cells-specific role for SHIP-1.	PIK3AP1 PDCD6IP NET1 INPPL1 SLC25A12	4.10e-06	54	153	5	21725061
Pubmed	Defining the membrane proteome of NK cells.	HSP90B1 PDCD6IP COPA CALU ANXA5 VPS50 NVL OAS2 RNF40 ADCY3 CEP350 NBAS EEF1G GTF2I KIF14 GIGYF2 RPL5 HSP90AB1	4.21e-06	1168	153	18	19946888
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	CDC42BPG SIN3B DNAH3 LAMA1 CT45A2 FAM227B CT45A9 CT45A8 EEF1G LOXHD1 PRICKLE2 PWWP3B TAS2R31 HSP90AB1	5.11e-06	736	153	14	29676528
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	HSP90B1 PDCD6IP ACADM COPA SMC1A SMPD4 MCM6 NUP214 MCCC1 MFAP1 EEF1G GTF2I SLC25A12 WDR82 OXSR1 HSD17B4 AGRN RPL5 HSP90AB1	5.82e-06	1318	153	19	30463901
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CWF19L2 HSP90B1 PDCD6IP SFSWAP COPA SMC1A ANXA5 SMPD4 MYO1B MFAP1 EEF1G SLC25A12 WDR82 HSD17B4 AGRN RPL5 HSP90AB1	6.16e-06	1082	153	17	38697112
Pubmed	The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization, and influences their tumor suppressor activity.	NET1 DLG4 PALS2	6.88e-06	9	153	3	17938206
Pubmed	CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma.	CDC42BPG ANXA5 DZIP1L MYO1B EEF1G SORBS3 EXOC6B MFN2 HSD17B4 RPL5 HSP90AB1	7.84e-06	468	153	11	36042349
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	UNC13B INPPL1 WNT7B MAEA RNF40 NUP214 STK32C FAAP100 ZFP36L2 KCNH2 SORBS3 MFN2 ARHGEF4 RGL2 ULK2 AGRN IQGAP3	8.10e-06	1105	153	17	35748872
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	HSP90B1 PDCD6IP SFSWAP COPA CALU SMC1A MYO1B MCM6 ABT1 MCCC1 EEF1G GTF2I CT45A3 TPX2 RPL5 HSP90AB1	8.18e-06	989	153	16	36424410
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	HSP90B1 PDCD6IP COPA SMC1A ANXA5 MYO1B MCM6 NUP214 MCCC1 MFAP1 EEF1G GTF2I SLC25A12 MICAL2 WDR82 PRR14L AGRN RPL5 HSP90AB1	8.42e-06	1353	153	19	29467282
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CDC42BPG EOGT PDCD6IP WNT7B MAEA ARHGEF38 VPS54 STK32C SMOC2 ADCY3 GTF2I FAM13A MICAL2 EXOC6B AFF1 OXSR1 ARHGEF4 PALS2 ZMYM4 KDM4B	9.18e-06	1489	153	20	28611215
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	UNC13B HSP90B1 ACADM COPA NET1 DIABLO KRT81 SMC1A MCM6 RNF40 NUP214 GTF2I SSX2IP GIGYF2 PLEKHA7 ZMYM4	9.98e-06	1005	153	16	19615732
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	CDC42BPG HSP90B1 PDCD6IP COPA CALU SMC1A INPPL1 ANXA5 MYO1B MCM6 NUP214 EEF1G MICAL2 AFF1 WDR82 OXSR1 RPL5 HSP90AB1	1.02e-05	1247	153	18	27684187
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	HSP90B1 ACADM COPA SMC1A MAEA SMPD4 MYO1B MCM6 RNF40 EEF1G GTF2I SLC25A12 MFN2 RARS2 HSD17B4 RPL5 IQGAP3 HSP90AB1	1.14e-05	1257	153	18	37317656
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	HSP90B1 PDCD6IP COPA SMC1A ANXA5 MCM6 NUP214 EEF1G TPX2 RPL5 HSP90AB1	1.30e-05	494	153	11	26831064
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	DCAF15 PDCD6IP COPA CALU SMC1A ANXA5 NUP214 SYF2 FAAP100 CEP350 NBAS GTF2I TPX2 KIF14 WDR82 IQGAP3 ZMYM4	1.43e-05	1155	153	17	20360068
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	HSP90B1 PDCD6IP SFSWAP NET1 DIABLO KRT86 EEF1G GTF2I GIGYF2 WDR82 LMAN2 MERTK ADGRL2 IQGAP3 HSP90AB1	1.49e-05	922	153	15	27609421
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	HSP90B1 KRT81 SMC1A GON4L MCCC1 EEF1G GIGYF2 RPL5 HSP90AB1	1.68e-05	330	153	9	32529326
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	HSP90B1 COPA CALU ITGA6 SMPD4 MYO1B CEP350 SYNE2 SSX2IP SORBS3 KIF14 WDR82 HSD17B4 ADGRL2 PLEKHA7 HSP90AB1	1.69e-05	1049	153	16	27880917
Pubmed	MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1.	HSP90B1 PDCD6IP MYO1B MCM6 LMAN2 HSD17B4 HSP90AB1	1.71e-05	182	153	7	30711629
Pubmed	Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain.	KRT81 KRT83 KRT86	1.78e-05	12	153	3	10692104
Pubmed	Expression of multiple adenylyl cyclase isoforms in human and dog thyroid.	ADCY3 ADCY6	1.92e-05	2	153	2	11162902
Pubmed	NVL2 is a nucleolar AAA-ATPase that interacts with ribosomal protein L5 through its nucleolar localization sequence.	NVL RPL5	1.92e-05	2	153	2	15469983
Pubmed	A missense mutation in the type II hair keratin hHb3 is associated with monilethrix.	KRT83 KRT86	1.92e-05	2	153	2	15744029
Pubmed	Total synthesis of human relaxin and human relaxin derivatives by solid-phase peptide synthesis and site-directed chain combination.	RLN1 RLN2	1.92e-05	2	153	2	2040595
Pubmed	Protective Role of Genetic Variants in HSP90 Genes-Complex in COPD Secondary to Biomass-Burning Smoke Exposure and Non-Severe COPD Forms in Tobacco Smoking Subjects.	HSP90B1 HSP90AB1	1.92e-05	2	153	2	34449539
Pubmed	Structural characterization by mass spectrometry of native and recombinant human relaxin.	RLN1 RLN2	1.92e-05	2	153	2	2076464
Pubmed	Selective down-regulation of the alpha6-integrin subunit in melanocytes by UVB light.	LAMA1 ITGA6	1.92e-05	2	153	2	15885076
Pubmed	Relaxin, insulin and diabetes: an intriguing connection.	RLN1 RLN2	1.92e-05	2	153	2	22698078
Pubmed	Isolation and analysis of the 3'-untranslated regions of the human relaxin H1 and H2 genes.	RLN1 RLN2	1.92e-05	2	153	2	10750025
Pubmed	A variable monilethrix phenotype associated with a novel mutation, Glu402Lys, in the helix termination motif of the type II hair keratin hHb1.	KRT81 KRT86	1.92e-05	2	153	2	9665406
Pubmed	A new mutation in the type II hair cortex keratin hHb1 involved in the inherited hair disorder monilethrix.	KRT81 KRT86	1.92e-05	2	153	2	9402962
Pubmed	Isozyme-Specific Role of SAD-A in Neuronal Migration During Development of Cerebral Cortex.	BRSK2 BRSK1	1.92e-05	2	153	2	30307479
Pubmed	Calmodulin-sensitive adenylyl cyclases mediate AVP-dependent cAMP production and Cl- secretion by human autosomal dominant polycystic kidney cells.	ADCY3 ADCY6	1.92e-05	2	153	2	22952279
Pubmed	Two human relaxin genes are on chromosome 9.	RLN1 RLN2	1.92e-05	2	153	2	6548703
Pubmed	Relaxin gene expression in human ovaries and the predicted structure of a human preprorelaxin by analysis of cDNA clones.	RLN1 RLN2	1.92e-05	2	153	2	6548702
Pubmed	Lack of an effect of collecting duct-specific deletion of adenylyl cyclase 3 on renal Na+ and water excretion or arterial pressure.	ADCY3 ADCY6	1.92e-05	2	153	2	24431204
Pubmed	Expression of human relaxin genes: characterization of a novel alternatively-spliced human relaxin mRNA species.	RLN1 RLN2	1.92e-05	2	153	2	8735594
Pubmed	Distribution of alpha 6 integrin subunit in developing mouse submandibular gland.	LAMA1 ITGA6	1.92e-05	2	153	2	8409377
Pubmed	Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer.	RLN1 RLN2	1.92e-05	2	153	2	26499396
Pubmed	RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9.	RLN1 RLN2	1.92e-05	2	153	2	23661525
Pubmed	Relaxin promotes prostate cancer progression.	RLN1 RLN2	1.92e-05	2	153	2	17363522
Pubmed	SAD: a presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release.	BRSK2 BRSK1	1.92e-05	2	153	2	16630837
Pubmed	Human seminal relaxin is a product of the same gene as human luteal relaxin.	RLN1 RLN2	1.92e-05	2	153	2	1572287
Pubmed	Analysis of the 5'-upstream regions of the human relaxin H1 and H2 genes and their chromosomal localization on chromosome 9p24.1 by radiation hybrid and breakpoint mapping.	RLN1 RLN2	1.92e-05	2	153	2	10601981
Pubmed	Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules.	ADCY3 ADCY6	1.92e-05	2	153	2	12782409
Pubmed	Serum relaxin levels in benign hypermobility syndrome.	RLN1 RLN2	1.92e-05	2	153	2	25322737
Pubmed	The relaxin peptide family--structure, function and clinical applications.	RLN1 RLN2	1.92e-05	2	153	2	20858209
Pubmed	Expression of the human relaxin H1 gene in the decidua, trophoblast, and prostate.	RLN1 RLN2	1.92e-05	2	153	2	2005217
Pubmed	Relaxin: structures, functions, promises, and nonevolution.	RLN1 RLN2	1.92e-05	2	153	2	7958621
Pubmed	SHIP2 interaction with the cytoskeletal protein Vinexin.	INPPL1 SORBS3	1.92e-05	2	153	2	16302969
Pubmed	SH2 domain-containing inositol 5-phosphatase (SHIP2) regulates de-novo lipogenesis and secretion of apoB100 containing lipoproteins in HepG2 cells.	INPPL1 APOB	1.92e-05	2	153	2	26188518
Pubmed	X-ray structure of human relaxin at 1.5 A. Comparison to insulin and implications for receptor binding determinants.	RLN1 RLN2	1.92e-05	2	153	2	1656049
Pubmed	Investigating the regulation of brain-specific kinases 1 and 2 by phosphorylation.	BRSK2 BRSK1	1.92e-05	2	153	2	18339622
Pubmed	Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer.	RLN1 RLN2	1.92e-05	2	153	2	29060928
Pubmed	Relaxin gene expression in human reproductive tissues by in situ hybridization.	RLN1 RLN2	1.92e-05	2	153	2	7829601
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	HSP90B1 PDCD6IP ACADM COPA CALU ANXA5 MAEA SMPD4 MYO1B MCCC1 NBAS EEF1G GTF2I SYNE2 VAMP7 KIF14 RARS2 LMAN2 ADGRL2	2.00e-05	1440	153	19	30833792
Pubmed	Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.	HSP90B1 EOGT ACADL ACADM COPA CALU OAS2 MCM6 RNF40 MCCC1 RPIA SLC25A12 GLCE RARS2 LMAN2 HSD17B4 AGRN RPL5 HSP90AB1	2.22e-05	1451	153	19	30550785
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	SIN3B COPA SMC1A NVL MCM6 NUP214 MCCC1 CCNF MFAP1 EEF1G GTF2I HSP90AB1	2.23e-05	624	153	12	33729478
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	PIK3AP1 VPS50 NVL AKAP3 SMPD4 RNF40 NUP214 CEP350 NBAS MFAP1 TPX2 KIF14 PRR14L	2.34e-05	733	153	13	34672954
Pubmed	Network organization of the human autophagy system.	HSP90B1 PDCD6IP COPA NET1 DIABLO SMC1A BRSK2 HSD17B4 ULK2 MAST3	2.57e-05	437	153	10	20562859
Pubmed	Host E3 ligase HUWE1 attenuates the proapoptotic activity of the MERS-CoV accessory protein ORF3 by promoting its ubiquitin-dependent degradation.	PDCD6IP COPA SMC1A INPPL1 ANXA5 MCM6 NUP214 GTF2I WDR82 HSD17B4 RPL5	2.65e-05	534	153	11	35032548
Pubmed	Identification of 14-3-3epsilon substrates from embryonic murine brain.	BRSK2 R3HDM2 GIGYF1 EEF1G BRSK1 HSP90AB1	2.73e-05	132	153	6	16944949
Pubmed	Interactome of the Autoimmune Risk Protein ANKRD55.	HSP90B1 SMC1A MCM6 EEF1G SLC25A12 RARS2 HSP90AB1	2.84e-05	197	153	7	31620119
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	PIK3AP1 CALU GON4L SMPD4 ODAD2 SYF2 SLFN13 SYNE2 SSX2IP PRICKLE2 PALS2 RGL2 HSP90AB1	2.96e-05	750	153	13	11230166
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	COPA CALU SMC1A MCM6 RNF40 MFAP1 EEF1G GTF2I TPX2 WDR82 OXSR1 PALS2	3.46e-05	653	153	12	33742100
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	CT45A6 CT45A1 KRT81 CT45A10 KRT83 SKIDA1 ARHGEF38 CT45A2 SMPD4 CT45A7 CT45A9 RPIA CT45A3 DLG4 RARS2 ARHGEF4 KDM4B	3.58e-05	1242	153	17	30973865
Pubmed	The Deubiquitinase USP37 Regulates Chromosome Cohesion and Mitotic Progression.	SIN3B SMC1A MCM6 GTF2I WDR82	3.60e-05	84	153	5	26299517
Pubmed	Mechanism of GTP hydrolysis by G-protein alpha subunits.	ADCY3 ADCY6 GNA15	3.65e-05	15	153	3	7937899
Pubmed	A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.	KRT81 KRT83 KRT86 DZIP1L ARHGEF12 NUP214 HSD17B4 HSP90AB1	3.99e-05	284	153	8	29459677
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	INPPL1 ARHGEF12 ITGA6 MYO1B NUP214 SCEL EEF1G GIGYF2 ADGRL2 PLEKHA7 HSP90AB1	4.42e-05	565	153	11	25468996
Pubmed	Comprehensive analysis of keratin gene clusters in humans and rodents.	KRT81 KRT83 KRT86	4.48e-05	16	153	3	15085952
Pubmed	Patterns of laminins and integrins in the embryonic ventricular zone of the CNS.	LAMA1 ITGA6 AGRN	4.48e-05	16	153	3	17948866
Pubmed	LHPP impedes energy metabolism by inducing ubiquitin-mediated degradation of PKM2 in glioblastoma.	CALU EEF1G HSP90AB1	4.48e-05	16	153	3	33948363
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	PDCD6IP ANXA5 VPS50 ARHGEF12 MYO1B SCEL VAMP7 TMPRSS11D LMAN2 OXSR1 PWWP3B IL1RN PLEKHA7 CCDC180 BBOX1	4.54e-05	1016	153	15	19056867
Pubmed	Quantitative Lys-ϵ-Gly-Gly (diGly) proteomics coupled with inducible RNAi reveals ubiquitin-mediated proteolysis of DNA damage-inducible transcript 4 (DDIT4) by the E3 ligase HUWE1.	HSP90B1 ANXA5 MAEA MCM6 MCCC1 GIGYF2 WDR82 RPL5 HSP90AB1	4.75e-05	377	153	9	25147182
Interaction	SLX4 interactions	CWF19L2 HSP90B1 PDCD6IP SMC1A NVL MCM6 NUP214 MCCC1 CEP350 MFAP1 EEF1G GTF2I TPX2 HSD17B4 IQGAP3 ZMYM4 HSP90AB1	1.30e-06	572	150	17	int:SLX4
Interaction	YWHAH interactions	CDC42BPG ABL2 PDCD6IP SFSWAP NET1 DIABLO INPPL1 R3HDM2 GIGYF1 CEP350 CCNF FAM13A ZFP36L2 KCNH2 SYNE2 SSX2IP KIF14 GIGYF2 ARHGEF4 PLEKHA7 RGL2 MAST3 HSP90AB1	7.00e-06	1102	150	23	int:YWHAH
Interaction	TOP3B interactions	UNC13B HSP90B1 PDCD6IP SMC1A INPPL1 WNT7B MAEA MYO1B R3HDM2 RNF40 APOB NUP214 STK32C FAAP100 CCNF GTF2I ZFP36L2 KCNH2 SSX2IP SORBS3 MFN2 KIF14 ARHGEF4 RGL2 ULK2 AGRN IQGAP3	1.07e-05	1470	150	27	int:TOP3B
Interaction	YWHAG interactions	ABL2 PDCD6IP ACADM NET1 DIABLO DZIP1L R3HDM2 GIGYF1 CEP350 CCNF MFAP1 EEF1G FAM13A ZFP36L2 SYNE2 SSX2IP KIF14 GIGYF2 DLG4 ARHGEF4 PLEKHA7 RGL2 MAST3 HSP90AB1	1.69e-05	1248	150	24	int:YWHAG
Interaction	CALM1 interactions	UNC13B PCP4 HSP90B1 ABL2 ACADM NET1 ANXA5 ARHGEF12 ITGA6 MYO1B CCNF GTF2I SYNE2 VAMP7 KIF14 IQGAP3	1.80e-05	626	150	16	int:CALM1
Interaction	TRIM37 interactions	DCAF15 CWF19L2 HSP90B1 COPA ANXA5 DZIP1L MAEA MYO1B GIGYF1 CEP350 EEF1G SSX2IP KIF14 GIGYF2 RPL5 HSP90AB1	1.95e-05	630	150	16	int:TRIM37
Interaction	PPP4R2 interactions	DCAF15 CT45A1 CALU INPPL1 CT45A2 MCM6 CT45A5	2.20e-05	113	150	7	int:PPP4R2
Interaction	CDC25C interactions	BRSK2 MYO1B GIGYF1 CCNF GIGYF2 BRSK1 PLEKHA7 MAST3	2.24e-05	156	150	8	int:CDC25C
Interaction	CAMSAP2 interactions	GIGYF1 CEP350 CCNF SSX2IP KIF14 GIGYF2 PLEKHA7 MAST3	3.97e-05	169	150	8	int:CAMSAP2
Interaction	YWHAZ interactions	CDC42BPG ABL2 DIABLO SMC1A MAEA R3HDM2 GIGYF1 CCNF MFAP1 EEF1G ADRA2C FAM13A ZFP36L2 SYNE2 SSX2IP KIF14 GIGYF2 DLG4 PRR14L ARHGEF4 PLEKHA7 RPL5 MAST3 HSP90AB1	4.13e-05	1319	150	24	int:YWHAZ
Interaction	ATG16L1 interactions	CDC42BPG CWF19L2 HSP90B1 SFSWAP COPA CALU SMC1A INPPL1 VPS50 SMPD4 VPS54 GIGYF1 SYF2 CEP350 NBAS EEF1G SLC25A12 SORBS3 KIF14 OXSR1 RPL5 HSP90AB1	4.94e-05	1161	150	22	int:ATG16L1
Interaction	HSF1 interactions	HSP90B1 PDCD6IP COPA CALU SMC1A ANXA5 MCM6 RNF40 EEF1G GTF2I SYNE2 TPX2 GIGYF2 BRSK1 HSP90AB1	5.09e-05	609	150	15	int:HSF1
Interaction	YWHAE interactions	ABL2 COPA DIABLO BRSK2 R3HDM2 GIGYF1 CCNF EEF1G FAM13A ZFP36L2 KCNH2 SSX2IP KIF14 GIGYF2 DLG4 ARHGEF4 MERTK BRSK1 PLEKHA7 RGL2 AGRN MAST3 HSP90AB1	5.53e-05	1256	150	23	int:YWHAE
Interaction	SH3RF3 interactions	HSP90B1 GIGYF1 GIGYF2 DLG4 MAST3	6.01e-05	56	150	5	int:SH3RF3
Interaction	IVNS1ABP interactions	HSP90B1 SMC1A MCM6 RPIA ZFP36L2 SYNE2 PRICKLE2 HSP90AB1	6.20e-05	180	150	8	int:IVNS1ABP
Interaction	UNC13C interactions	UNC13B ANXA5 HSP90AB1	8.46e-05	12	150	3	int:UNC13C
Interaction	NEMF interactions	HSP90B1 COPA SMC1A VPS50 CCNF RPL5	9.22e-05	98	150	6	int:NEMF
Interaction	HSP90B1 interactions	HSP90B1 ACADM CALU ANXA5 VPS50 MYOZ3 MYO1B APOB ODAD2 CCNF KIF14 AGRN ZMYM4 KDM4B HSP90AB1	1.05e-04	650	150	15	int:HSP90B1
Interaction	CCDC8 interactions	HSP90B1 PDCD6IP COPA SMC1A MYO1B MCM6 APOB CEP350 CCNF EEF1G GIGYF2 LMAN2 HSD17B4 RPL5 HSP90AB1	1.17e-04	656	150	15	int:CCDC8
Interaction	SYNE3 interactions	HSP90B1 COPA CALU SMPD4 NUP214 GIGYF1 CEP350 NBAS SYNE2 KIF14 LMAN2 PLEKHA7	1.25e-04	444	150	12	int:SYNE3
Cytoband	Ensembl 112 genes in cytogenetic band chrXq26	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5	7.03e-09	171	153	9	chrXq26
Cytoband	Xq26.3	CT45A6 CT45A1 CT45A2 CT45A3 CT45A5	3.15e-06	67	153	5	Xq26.3
GeneFamily	Heat shock 90kDa proteins	HSP90B1 HSP90AB1	2.82e-04	5	97	2	586
GeneFamily	Keratins, type II	KRT81 KRT83 KRT86	3.99e-04	27	97	3	609
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	NET1 ARHGEF38 ARHGEF12 ARHGEF4	4.35e-04	66	97	4	722
GeneFamily	Exocyst complex	EXOC6 EXOC6B	1.00e-03	9	97	2	1055
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY3 ADCY6	1.25e-03	10	97	2	53
GeneFamily	Acyl-CoA dehydrogenase family	ACADL ACADM	1.52e-03	11	97	2	974
GeneFamily	LIM domain containing	SCEL MICAL2 PRICKLE2	3.92e-03	59	97	3	1218
GeneFamily	CD molecules\|Integrin alpha subunits	ITGA10 ITGA6	4.12e-03	18	97	2	1160
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL	CT45A6 CT45A1 CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5	2.46e-10	69	152	9	M45681
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL	CT45A6 CT45A1 EOGT CT45A10 CT45A2 CT45A7 CT45A9 CT45A8 CT45A3 CT45A5	5.23e-10	104	152	10	M45682
Coexpression	YANG_BREAST_CANCER_ESR1_LASER_DN	MCCC1 KIF14 ARHGEF4 PALS2 BBOX1	7.74e-06	47	152	5	M11078
Coexpression	ONDER_CDH1_TARGETS_2_DN	KRT81 ITGA6 MYO1B SCEL ALS2CL RLN2 DUOX1 GNA15 ARHGEF4 ADGRL2 IL1RN AGRN	2.16e-05	473	152	12	M4306
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B ACADL WNT7B LAMA1 ARHGEF38 ITGA6 CCNF NRXN3 KIF14 IQGAP3	1.26e-09	192	152	10	25378b5e4b0cea8415ff125783511fc25a56fc00
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B ACADL ARHGEF38 MYO1B MCCC1 SCEL DUOX1 MICAL2 PLEKHA7	2.94e-08	199	152	9	8587bd98de7767a575088afbea07a1feb4516b9b
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	UNC13B ACADL ARHGEF38 MYO1B SCEL DUOX1 MICAL2 PLEKHA7	2.81e-07	188	152	8	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	Bronchial-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B ACADL ARHGEF38 MYO1B MCCC1 DUOX1 MICAL2 PLEKHA7	4.33e-07	199	152	8	5f7da3eab58ace6cddb3179a415cd839d5767958
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B ACADL ARHGEF38 MYO1B MCCC1 SCEL DUOX1 MICAL2	4.33e-07	199	152	8	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B ACADL ARHGEF38 MYO1B MCCC1 DUOX1 MICAL2 PLEKHA7	4.33e-07	199	152	8	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS-IL1RA+antiTNF-Epithelial_airway\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 ARHGEF38 ODAD2 IQCD TMPRSS11D CCDC180 SPINK5	1.56e-06	164	152	7	e4d4c59aebe5cacd4ecdb907facd044dc82a831d
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 ADCY3 CT45A9 CT45A5	1.98e-06	170	152	7	fefb07a7e308b620f946b9ff2b01e1796446fe38
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NET1 KRT86 ITGA6 ALS2CL MICAL2 OXSR1 IL1RN	4.59e-06	193	152	7	a5695ce2e24a62026ae28f3dea07ca4a435206b8
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UNC13B ACADL ARHGEF38 MYO1B SCEL DUOX1 MICAL2	4.74e-06	194	152	7	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NET1 MCM6 CCNF TPX2 KIF14 IL1RN IQGAP3	4.74e-06	194	152	7	effd38e51062b225ecabc7e1c50154e65495d559
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UNC13B ACADL ARHGEF38 MYO1B MCCC1 DUOX1 MICAL2	4.74e-06	194	152	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NET1 MCM6 CCNF TPX2 KIF14 IL1RN IQGAP3	4.91e-06	195	152	7	c1435e61e4f0cf457f26ae436936048932ceb0db
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UNC13B ACADL ARHGEF38 MYO1B SCEL DUOX1 MICAL2	4.91e-06	195	152	7	9406866f99555198a9be311fbd65751b70f35446
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 ARHGEF38 ODAD2 IQCD CCDC180 BBOX1 FYB2	4.91e-06	195	152	7	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	critical-Epithelial-Squamous\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SCEL TMPRSS11D GNA15 OXSR1 IL1RN TMPRSS11A SPINK5	5.25e-06	197	152	7	cfbdaada7169afb68455724ae87032ff311b2d89
ToppCell	moderate-Epithelial-Squamous\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ABL2 SCEL TMPRSS11D OXSR1 IL1RN TMPRSS11A SPINK5	5.25e-06	197	152	7	2e13881f917d4f62a5b3e968e41c57e43300d988
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 WNT7B ARHGEF38 ODAD2 CCDC180 FYB2 SPINK5	5.42e-06	198	152	7	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAH3 WNT7B ARHGEF38 ODAD2 CCDC180 FYB2 SPINK5	5.42e-06	198	152	7	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	Parenchymal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA6 MYOZ3 RNF40 ODAD2 STK32C ADCY3 SLFN13	5.61e-06	199	152	7	6f5ef959b51eccf1ffc2e5ddf0d83c62ca2257b2
ToppCell	Parenchymal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ITGA6 MYOZ3 RNF40 ODAD2 STK32C ADCY3 SLFN13	5.61e-06	199	152	7	1aa99d21bf61b86df4a966dc47634044430aa39f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH3 WNT7B ARHGEF38 ODAD2 IQCD CCDC180 SPINK5	5.79e-06	200	152	7	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	DNAH3 WNT7B ARHGEF38 ODAD2 IQCD CCDC180 SPINK5	5.79e-06	200	152	7	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 CT45A9 CT45A5	1.67e-05	157	152	6	b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCell	Control-Epithelial_airway\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DNAH3 WNT7B ARHGEF38 ODAD2 TMPRSS11D SPINK5	1.73e-05	158	152	6	35aee1c3b92169e73569331022833cb44ab7e7e8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	EPYC C1orf185 SLFN13 TPX2 KIF14 IQGAP3	2.07e-05	163	152	6	3f434015c0cbefb31eeda133c34f75384c5f7e22
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TPX2 KIF14 GNA15 IL1RN RGL2 IQGAP3	2.14e-05	164	152	6	1642a67c66eeb77a218e7814e3cfe517d9822955
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TPX2 KIF14 GNA15 IL1RN RGL2 IQGAP3	2.14e-05	164	152	6	25758fb8112baf296264122d5d4121f1ebb3d0fa
ToppCell	3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NET1 ITGA6 MCM6 SMOC2 RPIA ZFP36L2	2.45e-05	168	152	6	b08458164d270d625b8ee390122d1c2ce8c653db
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-T_cells-ILC3\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PIK3AP1 KRT81 KRT83 KRT86 GNA15 HSP90AB1	2.53e-05	169	152	6	d4a0bd792bddfa34332d7dc432ce253f50d98c6f
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	UNC13B ARHGEF12 MYO1B SCEL ADGRL2 FYB2	2.62e-05	170	152	6	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCEL SOWAHA TMPRSS11D IL1RN TMPRSS11A SPINK5	2.98e-05	174	152	6	97d4a40b536a67fa52f055eab26106d041bf3220
ToppCell	PND10-Epithelial-Epithelial_Airway-Basal-Basal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCEL SOWAHA TMPRSS11D IL1RN TMPRSS11A SPINK5	2.98e-05	174	152	6	f9f399244c7d12caf8118ec3117d477a39e35c3b
ToppCell	PND10-Epithelial-Epithelial_Airway-Basal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCEL SOWAHA TMPRSS11D IL1RN TMPRSS11A SPINK5	2.98e-05	174	152	6	e8440eea7c81864defa57c89e9b569ad8033e5c5
ToppCell	lung\|World / shred on tissue and cell subclass	ANXA5 EEF1G GTF2I SYNE2 RPL5 HSP90AB1	3.39e-05	178	152	6	7b1e371272328d6b6c3994382d64281ffc737db2
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	UNC13B MYO1B SCEL ALS2CL DUOX1 MICAL2	3.50e-05	179	152	6	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	droplet-Fat-Bat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFSWAP FAAP100 UBR7 ADRA2C SORBS3 MERTK	3.50e-05	179	152	6	e6224864eb76a2e9c1fc0c61513d9e936bb5c72c
ToppCell	droplet-Fat-Bat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFSWAP FAAP100 UBR7 ADRA2C SORBS3 MERTK	3.50e-05	179	152	6	9863ab3ceb160a4b1d9790033a4ac48845863d65
ToppCell	droplet-Fat-Bat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFSWAP FAAP100 UBR7 ADRA2C SORBS3 MERTK	3.50e-05	179	152	6	dfe110add7228cd834b35916cbcc849769a01bb9
ToppCell	facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DIABLO WNT7B APOB IQCD NRXN3 GLCE	3.72e-05	181	152	6	064057ab36c6d92c36572b73142b42d201709d7b
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SCEL TPX2 KIF14 PALS2 IL1RN IQGAP3	3.84e-05	182	152	6	21dcab170ffeef89faa9fee5008568cb6e15c694
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NET1 MCM6 CCNF TPX2 IL1RN IQGAP3	4.20e-05	185	152	6	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	AT1_cells-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	MYO1B SCEL ALS2CL MICAL2 ARHGEF4 AGRN	4.46e-05	187	152	6	f1dda349335e08dbfc8395d373924037f5ad2fd6
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	UNC13B ACADL ARHGEF38 MCCC1 DUOX1 HSD17B4	4.46e-05	187	152	6	5df9e1f5ca32217af255e76e6fb5afa346337811
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	UNC13B ARHGEF38 SCEL DUOX1 MICAL2 PLEKHA7	4.60e-05	188	152	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ACADL WNT7B ARHGEF38 SLFN13 KIF14 IQGAP3	4.73e-05	189	152	6	c8b8f860aaf6c73863cd79941db6b469c830ef06
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 CT45A9 CT45A5	4.87e-05	190	152	6	d24af6af3271e34afab744352afd28be8a7cc5c3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B ACADL WNT7B ARHGEF38 SMOC2 NRXN3	4.87e-05	190	152	6	c95032bb3ee2b3d40fdf48016acb46d6f78a48a6
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 CT45A9 CT45A5	4.87e-05	190	152	6	71a00f63fdd4eb4cc6f190d37e7a0417cdaafacb
ToppCell	PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	UNC13B ACADL CCNF TPX2 KIF14 IQGAP3	5.02e-05	191	152	6	39220f4a345e328f7fa4fd462a0abeea821b3e02
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	UNC13B ACADL ARHGEF38 MYO1B DUOX1 MICAL2	5.02e-05	191	152	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	UNC13B ACADL ARHGEF38 MYO1B DUOX1 MICAL2	5.17e-05	192	152	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	UNC13B ACADL ARHGEF38 MCCC1 DUOX1 MICAL2	5.17e-05	192	152	6	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B ACADL WNT7B LAMA1 NRXN3 SLFN13	5.17e-05	192	152	6	d3634574b2e8d2ded6446969361b70761b331aea
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	UNC13B ARHGEF38 MYO1B DUOX1 MICAL2 PLEKHA7	5.17e-05	192	152	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	AT1_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	MYO1B SCEL ALS2CL ARHGEF4 AGRN FYB2	5.17e-05	192	152	6	0444f9e9cef7403e220e862b5a787443d3f5c9ac
ToppCell	PCW_07-8.5-Epithelial-Epithelial_proliferating\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B ACADL WNT7B LAMA1 ITGA6 NRXN3	5.17e-05	192	152	6	1aa5e4d9b32013a3f272561dcb8377f6805706df
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UNC13B ACADL ARHGEF38 MCCC1 DUOX1 MICAL2	5.32e-05	193	152	6	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	CT45A6 CT45A1 CT45A10 CT45A2 CT45A9 CT45A5	5.32e-05	193	152	6	2f203f6f0c2135acb046c9351a633c3b5b254a46
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	UNC13B ACADL ARHGEF38 MCCC1 DUOX1 MICAL2	5.32e-05	193	152	6	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	UNC13B ACADL WNT7B ARHGEF38 SMOC2 NRXN3	5.47e-05	194	152	6	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	IPF-Multiplet-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 ARHGEF12 ODAD2 SYNE2 PRICKLE2 FYB2	5.63e-05	195	152	6	fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCell	IPF-Multiplet\|IPF / Disease state, Lineage and Cell class	DNAH3 ARHGEF12 ODAD2 SYNE2 PRICKLE2 FYB2	5.63e-05	195	152	6	eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCell	moderate-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DZIP1L ODAD2 SLFN13 CFAP74 CCDC180	5.63e-05	195	152	6	3486eae5fdb062a75a907b896c9d7b396d2aa195
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.79e-05	196	152	6	6d80e23f6a1725a3f5ea7263233c55c2ea56f977
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.79e-05	196	152	6	bf1d3fae8c01bb3d17c2dafad92b94937c663acd
ToppCell	critical-Epithelial-Ciliated\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DZIP1L ODAD2 IQCD CFAP74 CCDC180	5.79e-05	196	152	6	27b855c6e1ae44f16db998cf0e81bd686b9cee7e
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 ARHGEF12 ODAD2 SYNE2 PRICKLE2 FYB2	5.79e-05	196	152	6	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.79e-05	196	152	6	3dd7ed1dfac8d90c8a44f0ae00128bb46d9ef496
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.79e-05	196	152	6	4f649e3bfd21f21682678828673843a7d51c4ff2
ToppCell	BAL-Control-Myeloid-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.79e-05	196	152	6	799c290fb3dfacb666dd0dc3c43ec8a86b697ec7
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	DNAH3 ARHGEF12 ODAD2 SYNE2 PRICKLE2 FYB2	5.79e-05	196	152	6	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	BAL-Control-Myeloid-Myeloid-proliferating_Myeloid_cells\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.79e-05	196	152	6	0c003a767c3b58605099dab64b9df0d8e5d8bc4b
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	DCAF15 MYO1B CCNF TPX2 KIF14 AGRN	5.96e-05	197	152	6	1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf
ToppCell	PSB-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH3 DZIP1L ODAD2 IQCD CFAP74 CCDC180	5.96e-05	197	152	6	6865f4831eb23794fb88a8649d48d497bbae3f44
ToppCell	Control-Myeloid-proliferating_Myeloid_cells\|Control / Disease group,lineage and cell class （2021.01.30）	MCM6 CCNF SLFN13 TPX2 KIF14 IQGAP3	5.96e-05	197	152	6	ddbe3fe078766bb55f0d7ca1aeb8f9e4aa696d8e
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH3 DZIP1L SYNE2 CFAP74 CCDC180 FYB2	5.96e-05	197	152	6	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	facs-Tongue-nan-3m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDCD6IP COPA NET1 CALU ARHGEF12 AFF1	6.13e-05	198	152	6	2f03f8897dd7cce6d8296638e14e11ec16bcf624
ToppCell	critical-Epithelial-Ciliated\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DNAH3 DZIP1L ODAD2 SLFN13 CFAP74 CCDC180	6.13e-05	198	152	6	ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UNC13B ACADL ARHGEF38 MCCC1 DUOX1 MICAL2	6.13e-05	198	152	6	f948391296c261c473d339069a6d0f20ccd6f38f
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_2-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ACADL ARHGEF38 MYO1B DUOX1 MICAL2 SPINK5	6.13e-05	198	152	6	de5748c2b66ecc432974cf095ecd241369579f7c
ToppCell	LPS_only-Epithelial_airway-airway_epithelial\|LPS_only / Treatment groups by lineage, cell group, cell type	DNAH3 WNT7B ODAD2 SCEL CCDC180 SPINK5	6.13e-05	198	152	6	e035380578c01b0243bfef29ca9b50cc17cce771
ToppCell	LPS_only-Epithelial_airway\|LPS_only / Treatment groups by lineage, cell group, cell type	DNAH3 WNT7B ODAD2 SCEL CCDC180 SPINK5	6.13e-05	198	152	6	ba090210392e001a3f7bdf09371b3f0e0c8c7ef3
ToppCell	facs-Tongue-nan-3m\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDCD6IP COPA NET1 CALU ARHGEF12 AFF1	6.13e-05	198	152	6	f2a4057f038ef7225a5b98a7ab068c30dff4eadd
ToppCell	Bronchus_Control_(B.)-Endothelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	TCERG1L KRT81 BRSK2 ARHGEF12 SMOC2 ARHGEF4	6.13e-05	198	152	6	feac39036b5c0ab97b524cc366286942d136d42f
ToppCell	Caecum-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	NET1 KRT81 CCNF TPX2 KIF14 IQGAP3	6.30e-05	199	152	6	64d1e495307a91bc012130613126d86e0cf170b0
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NVL MCM6 ABT1 ADCY3 NBAS TPX2	6.30e-05	199	152	6	fd1d1b95e01719e3d0a17d9d1f29717a47209d32
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	UNC13B PCP4 SCEL ALS2CL DUOX1 AGRN	6.30e-05	199	152	6	f8846446ebbc4948cdc69640782db1358bbdc486
ToppCell	(07)_Ionocytes\|World / shred by cell type by condition	INPPL1 SLC25A12 KCNH2 SYNE2 TPX2 FYB2	6.30e-05	199	152	6	8194777d367405a7840787e977854b5c07e3bd6b
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	UNC13B PCP4 SCEL ALS2CL DUOX1 AGRN	6.30e-05	199	152	6	fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5
ToppCell	Mild/Remission-Developping_Plasmablast\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HSP90B1 CALU MCM6 CCNF TPX2 KIF14	6.30e-05	199	152	6	58c772ec763109a4009f52424fbb214fc23d0c09
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	UNC13B PCP4 SCEL ALS2CL DUOX1 AGRN	6.30e-05	199	152	6	3e35ee426ef06f9af568c37349b62dd1ee9b97ea
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NVL MCM6 ABT1 ADCY3 NBAS TPX2	6.30e-05	199	152	6	91882af9dc7265c9b419f4415cbcf656087a2ab3
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NVL SMPD4 ABT1 ADCY3 NBAS TPX2	6.48e-05	200	152	6	d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Ciliated\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	DNAH3 DZIP1L ODAD2 IQCD CFAP74 CCDC180	6.48e-05	200	152	6	6a2ccc71a0cbe04a542c379b28b5006de53981c3
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	SIN3B ARHGEF12 OAS2 SYNE2 ADGRL2 RGL2	6.48e-05	200	152	6	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DNAH3 ODAD2 IQCD CCDC180 BBOX1 FYB2	6.48e-05	200	152	6	4992dbf0514d674017315dbd20d91dfec0c608e9
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	NVL SMPD4 ABT1 ADCY3 NBAS TPX2	6.48e-05	200	152	6	3d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MCM6 ADCY3 SLFN13 TPX2 KIF14 IQGAP3	6.48e-05	200	152	6	2afbb5b5742b956993796621fea7e0c9888754a1
ToppCell	356C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MCM6 ADCY3 SLFN13 TPX2 KIF14 IQGAP3	6.48e-05	200	152	6	4462ebd5d4632788f10a93fadd2babae701c754f
Drug	Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; HL60; HG-U133A	EPM2A CALU ARHGEF12 ADCY3 CCNF SLC25A12 SSX2IP WDR82 IL1RN KDM4B	7.21e-07	197	149	10	1556_DN
Drug	Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; HL60; HG-U133A	EPM2A SFSWAP NET1 ZFP36L2 MFN2 CFAP74 WDR82 LMAN2 IL1RN AGRN	7.55e-07	198	149	10	1609_DN
Drug	ATBI	KRT81 KRT83 KRT86 IL1RN	5.02e-06	18	149	4	CID000505862
Drug	arborinine	KRT81 KRT83 ANXA5	5.41e-06	6	149	3	CID005281832
Drug	Oxymetazoline hydrochloride [2315-02-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A	ABL2 COPA OAS2 NUP214 ADCY3 ZFP36L2 KCNH2 MERTK MAST3	5.73e-06	195	149	9	2278_DN
Drug	Paclitaxel [33069-62-4]; Down 200; 4.6uM; HL60; HG-U133A	UNC13B DNAH3 HSP90B1 ACADM MAEA CEP350 ZFP36L2 PALS2 IL1RN	5.97e-06	196	149	9	2043_DN
Drug	irofulven	EPM2A ERCC5 SMC1A RPIA IL1RN	2.07e-05	51	149	5	CID000148189
Drug	Betamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A	NET1 FAM13A ZFP36L2 KCNH2 AFF1 WDR82 PHOX2B KDM4B	2.84e-05	183	149	8	1590_UP
Drug	Monobenzone [103-16-2]; Down 200; 20uM; MCF7; HT_HG-U133A	COPA KRT83 CEP350 CCNF TPX2 SORBS3 KIF14 SPINK5	3.19e-05	186	149	8	3391_DN
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A	SMC1A CCNF ZFP36L2 TPX2 KIF14 MERTK KDM4B MAST3	3.57e-05	189	149	8	3214_DN
Drug	Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; HL60; HT_HG-U133A	HSP90B1 COPA CALU GTF2I FAM13A GLCE SSX2IP MFN2	3.71e-05	190	149	8	1286_UP
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	HSP90B1 EPM2A SMC1A ITGA6 ALS2CL ZFP36L2 KCNH2 SSX2IP	4.14e-05	193	149	8	4118_DN
Drug	METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE	HSP90B1 HSP90AB1	4.25e-05	2	149	2	DB08464
Drug	2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE	HSP90B1 HSP90AB1	4.25e-05	2	149	2	DB08465
Drug	melicopicine	KRT81 KRT83	4.25e-05	2	149	2	CID000101253
Drug	tebuquine	KRT81 KRT83	4.25e-05	2	149	2	CID000071991
Drug	3,5-di-O-galloylquinic acid	KRT81 KRT83	4.25e-05	2	149	2	CID000460896
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A	EPM2A COPA CALU GTF2I MFN2 ARHGEF4 MAST3 SPINK5	4.30e-05	194	149	8	4176_DN
Drug	(+) -Levobunolol hydrochloride [47141-41-3]; Down 200; 12.2uM; MCF7; HT_HG-U133A	DCAF15 COPA SMC1A ITGA10 RLN1 ARHGEF4 MERTK KDM4B	4.46e-05	195	149	8	4980_DN
Drug	AC1L1BIT	CALU KRT81 KRT83 KRT86 WNT7B	4.59e-05	60	149	5	CID000001457
Drug	Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A	ABL2 EPYC BRSK2 FAAP100 AFF1 ADGRL2 BBOX1 KDM4B	4.62e-05	196	149	8	5088_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; PC3; HT_HG-U133A	VPS50 ARHGEF38 ADCY6 RLN1 ZFP36L2 KCNH2 ADGRL2 MAST3	4.79e-05	197	149	8	4438_UP
Drug	Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; HL60; HG-U133A	UNC13B DNAH3 ACADM ADCY3 SSX2IP TPX2 WDR82 PALS2	4.79e-05	197	149	8	2012_DN
Drug	Biperiden hydrochloride [1235-82-1]; Down 200; 11.4uM; PC3; HT_HG-U133A	EPYC SMC1A ITGA10 MYOZ3 OAS2 ZFP36L2 MERTK IL1RN	4.79e-05	197	149	8	4684_DN
Drug	Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A	EPM2A SMC1A ADCY3 RLN1 SSX2IP SORBS3 ARHGEF4 SPINK5	5.14e-05	199	149	8	4985_DN
Drug	Ald1.1-H_000455; Up 200; 10uM; MCF7; HT_HG-U133A	ABL2 ITGA6 MYO1B KCNH2 AFF1 IL1RN ULK2 SPINK5	5.14e-05	199	149	8	7516_UP
Drug	tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A	GON4L NUP214 CCNF SSX2IP SORBS3 IL1RN ZMYM4 SPINK5	5.33e-05	200	149	8	375_UP
Disease	MONILETHRIX	KRT81 KRT83 KRT86	1.02e-07	3	139	3	158000
Disease	Beaded hair	KRT81 KRT83 KRT86	1.02e-07	3	139	3	cv:C0546966
Disease	monilethrix (is_implicated_in)	KRT81 KRT83 KRT86	1.02e-07	3	139	3	DOID:0050472 (is_implicated_in)
Disease	Monilethrix	KRT81 KRT83 KRT86	4.08e-07	4	139	3	C0546966
Disease	hair disease (is_implicated_in)	KRT81 KRT86	2.20e-05	2	139	2	DOID:421 (is_implicated_in)
Disease	Autism Spectrum Disorders	SFSWAP NRXN3 GTF2I DLG4 IQGAP3	5.23e-05	85	139	5	C1510586
Disease	serine/threonine-protein kinase BRSK2 measurement	BRSK2 BRSK1	6.59e-05	3	139	2	EFO_0803063
Disease	metabolite measurement	PCP4 ACADL ACADM MCM6 MCCC1 NBAS KCNH2 MICAL2 SYNE2 GNA15 BBOX1	7.31e-05	560	139	11	EFO_0004725
Disease	developmental disorder of mental health (implicated_via_orthology)	SIN3B GIGYF1 GIGYF2 DLG4	8.48e-05	49	139	4	DOID:0060037 (implicated_via_orthology)
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipid measurement	EXOC6 R3HDM2 APOB AFF1 WDR82	1.70e-04	109	139	5	EFO_0004639, EFO_0008317, EFO_0008596
Disease	blood chromium measurement	TCERG1L MICAL2 ARHGEF4	2.46e-04	26	139	3	EFO_0007579
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	R3HDM2 APOB SYNE2 AFF1 DLG4	2.77e-04	121	139	5	EFO_0008595, EFO_0020943
Disease	urate measurement	CDC42BPG DNAH3 GON4L MCM6 R3HDM2 SYF2 FAM13A WDR82 LMAN2 PALS2 ADGRL2 KDM4B MAST3	3.27e-04	895	139	13	EFO_0004531
Disease	Colorectal Carcinoma	UNC13B DNAH3 TCERG1L LAMA1 AKAP3 MYO1B APOB STK32C ZFP36L2 TPX2 ZMYM4	5.10e-04	702	139	11	C0009402
Disease	glomerular filtration rate, renal transplant outcome measurement	NBAS MICAL2 ADGRL2	6.00e-04	35	139	3	EFO_0005199, EFO_0005208
Disease	Williams Syndrome	GTF2I DLG4	6.06e-04	8	139	2	C0175702
Disease	encephalitis (biomarker_via_orthology)	SYF2 IL1RN	7.76e-04	9	139	2	DOID:9588 (biomarker_via_orthology)
Disease	Paroxysmal atrial fibrillation	CALU C1orf185 GTF2I KCNH2 SYNE2	8.82e-04	156	139	5	C0235480
Disease	familial atrial fibrillation	CALU C1orf185 GTF2I KCNH2 SYNE2	8.82e-04	156	139	5	C3468561
Disease	Persistent atrial fibrillation	CALU C1orf185 GTF2I KCNH2 SYNE2	8.82e-04	156	139	5	C2585653
Disease	lipoprotein-associated phospholipase A(2) measurement	APOB GLCE SSX2IP	8.90e-04	40	139	3	EFO_0004746
Disease	Atrial Fibrillation	CALU C1orf185 GTF2I KCNH2 SYNE2	9.87e-04	160	139	5	C0004238
Disease	Neurodevelopmental Disorders	SMC1A BRSK2 GIGYF2 DLG4	9.95e-04	93	139	4	C1535926
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement, lipid measurement	EXOC6 R3HDM2 APOB AFF1	1.08e-03	95	139	4	EFO_0004529, EFO_0008317, EFO_0008596
Disease	triglycerides in large LDL measurement	APOB SYNE2 AFF1	1.10e-03	43	139	3	EFO_0022319
Disease	hearing impairment	DIABLO POU3F4 LOXHD1 HSD17B4	1.21e-03	98	139	4	C1384666
Disease	Weight Gain	ACADM ANXA5 ARHGEF12 MYO1B	1.40e-03	102	139	4	C0043094
Disease	Sudden infant death syndrome	ACADM PHOX2B	1.41e-03	12	139	2	C0038644
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	APOB SYNE2 AFF1 DLG4	1.45e-03	103	139	4	EFO_0008595, EFO_0020944
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB AFF1	1.62e-03	106	139	4	EFO_0008317, EFO_0008596
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB AFF1	1.85e-03	110	139	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB AFF1	1.85e-03	110	139	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB AFF1	1.85e-03	110	139	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	triglyceride measurement, intermediate density lipoprotein measurement	R3HDM2 APOB SYNE2 AFF1	1.91e-03	111	139	4	EFO_0004530, EFO_0008595
Disease	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	NUP214 ZFP36L2 RPL5	2.02e-03	53	139	3	C1961099
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	R3HDM2 APOB FAM13A AFF1 DLG4 LMAN2	2.02e-03	276	139	6	EFO_0004612, EFO_0020943
Disease	Metastatic melanoma	OXSR1 BRSK1 ULK2	2.13e-03	54	139	3	C0278883
Disease	low density lipoprotein triglyceride measurement	SFSWAP APOB	2.22e-03	15	139	2	EFO_0009946
Disease	Williams-Beuren syndrome (implicated_via_orthology)	GTF2I DLG4	2.22e-03	15	139	2	DOID:1928 (implicated_via_orthology)
Disease	amenorrhea, response to antineoplastic agent	VPS50 APOB	2.22e-03	15	139	2	EFO_0010269, GO_0097327
Disease	cholesterol to total lipids in large HDL percentage	APOB FAM13A AFF1	2.24e-03	55	139	3	EFO_0022234
Disease	triglycerides in LDL measurement	APOB SYNE2 AFF1	2.36e-03	56	139	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	EXOC6 APOB AFF1	2.36e-03	56	139	3	EFO_0022325
Disease	primary autosomal recessive microcephaly (is_implicated_in)	PDCD6IP KIF14	2.53e-03	16	139	2	DOID:0070296 (is_implicated_in)
Disease	triglycerides in VLDL measurement	EXOC6 APOB AFF1	2.74e-03	59	139	3	EFO_0022326
Disease	phospholipids in VLDL measurement	EXOC6 APOB AFF1	2.74e-03	59	139	3	EFO_0022301
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	APOB AFF1 AGRN	2.74e-03	59	139	3	EFO_0022260
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DLG4 KDM4B	2.86e-03	17	139	2	DOID:0060307 (is_implicated_in)
Disease	total lipids in VLDL measurement	EXOC6 APOB AFF1	2.88e-03	60	139	3	EFO_0022314
Disease	Acute Myeloid Leukemia, M1	ANXA5 NUP214 GTF2I AGRN	2.94e-03	125	139	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	ANXA5 NUP214 GTF2I AGRN	2.94e-03	125	139	4	C1879321
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	R3HDM2 APOB FAM13A SYNE2 AFF1	2.98e-03	206	139	5	EFO_0004612, EFO_0020947
Disease	free cholesterol in very large VLDL measurement	EXOC6 APOB AFF1	3.02e-03	61	139	3	EFO_0022274
Disease	free cholesterol in VLDL measurement	EXOC6 APOB AFF1	3.02e-03	61	139	3	EFO_0022276
Disease	triglycerides:total lipids ratio, intermediate density lipoprotein measurement	R3HDM2 APOB SYNE2 AFF1	3.12e-03	127	139	4	EFO_0008595, EFO_0020947
Disease	phospholipids in large VLDL measurement	EXOC6 APOB AFF1	3.16e-03	62	139	3	EFO_0022169
Disease	total lipids in chylomicrons and extremely large VLDL measurement	APOB AFF1 AGRN	3.16e-03	62	139	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	EXOC6 APOB AFF1	3.16e-03	62	139	3	EFO_0022313
Disease	phospholipids in very large VLDL measurement	EXOC6 APOB AFF1	3.16e-03	62	139	3	EFO_0022299
Disease	response to platinum based chemotherapy	ODAD2 NRXN3	3.21e-03	18	139	2	EFO_0004647
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	APOB AFF1 AGRN	3.30e-03	63	139	3	EFO_0022292
Disease	cholesterol in large VLDL measurement	EXOC6 APOB AFF1	3.61e-03	65	139	3	EFO_0021902
Disease	cholesterol in very large VLDL measurement	EXOC6 APOB AFF1	3.61e-03	65	139	3	EFO_0022230
Disease	total lipids in small VLDL	APOB AFF1 HSD17B4	3.93e-03	67	139	3	EFO_0022148
Disease	total lipids in large VLDL	EXOC6 APOB AFF1	3.93e-03	67	139	3	EFO_0022175
Disease	very low density lipoprotein cholesterol measurement, lipid measurement	EXOC6 R3HDM2 APOB AFF1 HSD17B4	3.95e-03	220	139	5	EFO_0004529, EFO_0008317
Disease	glycine measurement	ACADM R3HDM2 FAM13A MAST3	4.08e-03	137	139	4	EFO_0009767
Disease	triglycerides in very small VLDL measurement	R3HDM2 APOB AFF1	4.10e-03	68	139	3	EFO_0022144
Disease	free cholesterol in large VLDL measurement	EXOC6 APOB AFF1	4.10e-03	68	139	3	EFO_0022265
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB SYNE2 AFF1	4.26e-03	224	139	5	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB AFF1 HSD17B4	4.26e-03	224	139	5	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	EXOC6 R3HDM2 APOB AFF1 HSD17B4	4.34e-03	225	139	5	EFO_0008317, EFO_0010351

Protein segments in the cluster

Peptide	Gene	Start	Entry
VVQAFQKAAKRRSEY	ALS2CL	111	Q60I27
EAKRQFARNQKDFRI	FAM227B	436	Q96M60
FARNQKDFRILQAKA	FAM227B	441	Q96M60
IKRNHDRFKEDFFQS	EOGT	166	Q5NDL2
AAREKESFNLKRAQE	RNF40	896	O75150
RNKFAFREAVSKLEL	ABL2	1131	P42684
EHDIFRKSVRKFFQE	ACADL	56	P28330
RLVQVFQSKQFRSAK	ADCY6	121	O43306
EQKKNFERERRSFTE	SSX2IP	441	Q9Y2D8
AEKQQKADFRASQAR	IQCD	276	Q96DY2
KADFRASQARVAKIQ	IQCD	281	Q96DY2
KVAQAREKRFTFVLA	ADRA2C	371	P18825
QVKDNTFNREEKLFR	ARHGEF38	336	Q9NXL2
FDSFQEAQIKRKARN	CDKL4	286	Q5MAI5
LFRNSDVKKDFRSVR	AGRN	1176	O00468
KAFVKALEQRFNRER	ARHGEF4	341	Q9NR80
REIFQNSKFKAIDER	C1orf185	41	Q5T7R7
AVRKRFFESIIKEAA	CT45A5	156	P0DMU8
FNKERTRNIVKFDLR	ADGRL2	221	O95490
VADKSRFTNVKQFIA	GLCE	261	O94923
KTEREQFVEFRDKNR	CALU	231	O43852
VVANFKKRCFSELIR	DIABLO	26	Q9NR28
KEFQATARKFAREEI	ACADM	46	P11310
LFNIRKEFRKNFATS	ANXA5	281	P08758
FQEEQNVRSKNFRLK	CCDC180	966	Q9P1Z9
QKKRSESFRFQQENL	PIK3AP1	636	Q6ZUJ8
AVRKRFFESIIKEAA	CT45A7	156	P0DMV0
RQKKDSRFQTFVQDA	ARHGEF12	901	Q9NZN5
EKNTEFQQRFILKRD	R3HDM2	246	Q9Y2K5
FEEFKKLIRNRQSEA	RLN2	126	P04090
KRNAFRIQVEKVFSI	NVL	51	O15381
SKRRFFFRVSEEQQK	CDC42BPG	1406	Q6DT37
RNSKKELNDIRFEFT	OXSR1	441	O95747
FSNSEKAKNIFRIRF	NET1	456	Q7Z628
QEIRRRFGKKVTSFQ	DUOX1	996	Q9NRD9
LRVQREQKARKFSEF	DZIP1L	491	Q8IYY4
KEQVANSAFVERVRK	HSP90AB1	491	P08238
NKSRFVDFQKVRIQE	MCM6	196	Q14566
FAESKIKSFRRQVQE	KIF14	1471	Q15058
ARAQEDFFQKFGKVR	EPM2A	311	O95278
NAKAAAQKFIRDNFL	KLHL31	186	Q9H511
FFKQKAAGVRDVFER	MFAP1	416	P55081
KRFRAAQKNIDRETS	MAEA	31	Q7L5Y9
AKEFAKQFLERRAKQ	GIGYF1	951	O75420
GAVVFQKRQERNKRF	LMAN2	341	Q12907
RKRVQETKFGNAFTE	MERTK	526	Q12866
GKTFVEINRIFAKRN	SLC2A7	471	Q6PXP3
AVRKRFFESIIKEAA	CT45A10	156	P0DMU9
FFQQEERARAKAKRE	SPINK5	476	Q9NQ38
KSLNSRFAAFIDKVR	KRT86	111	O43790
KFEGQSRKFIIANAR	KCNH2	21	Q12809
KREQKQFFERKSASR	LOXHD1	1141	Q8IVV2
KEARKFFRQIISALD	BRSK2	116	Q8IWQ3
RFNRIKKINKNDFAS	EPYC	151	Q99645
RAAVAIQSQFRKFQK	PCP4	41	P48539
RFQNKCSDIVFARKT	PDCD6IP	686	Q8WUM4
RESFEDQRKKALQFA	CWF19L2	866	Q2TBE0
AVRKRFFESIIKEAA	CT45A3	156	Q8NHU0
AFQTLARAKKRKENF	MDM1	696	Q8TC05
DARSQKNTKVDFFAV	NRXN3	496	Q9Y4C0
KNRAASFQAERKFNA	KDM4B	661	O94953
DFQFRALKKVRIFDS	NUP214	16	P35658
LFQKFVEERDVFKTR	METTL18	336	O95568
FAQFRKNERDKQKLI	EXOC6B	781	Q9Y2D4
KQIDDNRKFSLFAER	ITGA6	946	P23229
ATDTQNIRKVFKDVR	GNA15	346	P30679
FSDLKQFQDQKRSQR	OAS2	81	P29728
RKKLRDFEDNFFRQN	FAM13A	966	O94988
SERVSFLKKAVDQRN	FAAP100	466	Q0VG06
FFKKFRNQNIVLSAR	NBAS	716	A2RRP1
IFAQFRKNDRDKQKL	EXOC6	771	Q8TAG9
VNSIVKIQAFFRARK	IQGAP3	821	Q86VI3
AKERAFKRQFVEHAS	MFN2	656	O95140
EEFKRAAVPRFVQQK	SMPD4	401	Q9NXE4
SDELEQFAKQFKQRR	POU3F4	191	P49335
NVLNFFFADKKNKRR	OR1L1	11	Q8NH94
FQNARAKESRRSAKI	PRICKLE2	326	Q7Z3G6
IRELREKSEKFAFQA	HSP90B1	66	P14625
SQFLEEKRKAFVRRD	PALS2	276	Q9NZW5
FFQAEDRFVRRKKKA	ABT1	76	Q9ULW3
IKSFDRHFEKNRNNA	APOB	3201	P04114
AVRKRFFESIIKEAA	CT45A1	156	Q5HYN5
AVRKRFFESIIKEAA	CT45A9	156	P0DMV2
TSEAKEFAKQFLERR	GIGYF2	1181	Q6Y7W6
EFAKQFLERRAKQKA	GIGYF2	1186	Q6Y7W6
RQVSLTAVKQRFEDK	CCNF	506	P41002
TINADSRKKFDVFFR	DNAH3	1966	Q8TD57
VKDRFLRQLDFNSSK	COPA	336	P53621
KNFKTAATFARRLLE	COPA	1116	P53621
QQFADNDVSRFKAIK	HSD17B4	546	P51659
AVRKRFFESIIKEAA	CT45A2	156	Q5DJT8
EQQAFEKSRKFLRQL	GON4L	1706	Q3T8J9
FSKQARAKLQRELFF	BBOX1	96	O75936
TLESNVKKNNRVEFR	CEP350	111	Q5VT06
ERESAQVVKKRNTFL	ADCY3	596	O60266
KEARKFFRQIVSALD	BRSK1	131	Q8TDC3
RKAFDRATKLEQEFT	DLG4	671	P78352
EQLESARREAKKSFN	MCCC1	226	Q96RQ3
LSERRDSFKKQEAVQ	MAST3	1256	O60307
NEFFRRAKFKSLTVV	ITGA10	1071	O75578
AVRKRFFESIIKEAA	CT45A8	156	P0DMV1
TDLSENRKQDKRFAF	IL1RN	111	P18510
NRKQDKRFAFIRSDS	IL1RN	116	P18510
FQRLDKLRKNAFASV	EEF1G	346	P26641
RGRAFVNTRKDFQKD	GTF2I	61	P78347
NSRQAFDFLKTKERQ	SLFN13	146	Q68D06
SEKQAEQKVRRAFEA	C3orf56	6	Q8N813
FSVLRAQNRDKLFKV	CFAP74	1146	Q9C0B2
AVRKRFFESIIKEAA	CT45A6	156	P0DMU7
AIAKAKEFVADIFRR	DCAF15	316	Q66K64
KSLNSRFAAFIDKVR	KRT83	116	P78385
KVVVVEKRDSFSRNN	MICAL2	111	O94851
DKSFESFLQESRQRK	MICAL2	1666	O94851
QQKRKRVLEFQDFTV	PRR14L	2081	Q5THK1
RQFDNFKRVFKVVEE	FIBP	136	O43427
RFIVIADFRKDSKNL	RPIA	191	P49247
NSIERVKRQKISFAD	TAS2R31	31	P59538
DKSVAKAAQEFFQRL	RARS2	216	Q5T160
NFDKRRKEFAVLSEL	RGL2	456	O15211
KAKQARNSQFDFLRF	SFSWAP	231	Q12872
INERNAKFNKKAERF	SYF2	211	O95926
FKLEERSNFFAIIRK	SYNE2	2831	Q8WXH0
SAKEELKRFEAFQRQ	SYNE2	6171	Q8WXH0
KAARDRANKNLVDFI	PWWP3B	546	Q5H9M0
FEEFKKLIRNRQSEA	RLN1	126	P04808
AETIANVAKFKRARR	ODAD2	556	Q5T2S8
VRNFKELRAKFQNLD	FYB2	6	Q5VWT5
QKVNRATERIFKESQ	LAMA1	1641	P25391
FFRLAQQEKEDAKRI	ERCC5	996	P28715
DDFTVINRRKKVASN	SKIDA1	821	Q1XH10
HRRAFFFQEKSQIQK	PLEKHA7	796	Q6IQ23
DRTQRKDFIFVSARK	INPPL1	386	O15357
QEFSFFDKVRRVLKS	SIN3B	306	O75182
AQKKASFLRAQERAA	RPL5	281	P46777
QDFVIFNREKLKRSQ	STK32C	431	Q86UX6
EKKDLRSVFFNFIRN	AKAP3	586	O75969
QAEALTRKNKEFFAR	AFF1	1161	P51825
KLTVNDFVRDKFTRR	SLC25A12	406	O75746
FRLVQKRKDQEHFFN	TCERG1L	551	Q5VWI1
KTFKESNLRNQFIRA	TMPRSS11D	86	O60235
KEFEQFNRRLNEVSK	VPS50	821	Q96JG6
DFSRRFVDAREIKKN	WNT7B	161	P56706
FRVAKVFRENSDKIN	WDR82	11	Q6UXN9
DRFKQFVNNVAVVKE	SOWAHA	56	Q2M3V2
VAERKYTQEQARKEF	SMOC2	91	Q9H3U7
KQQDFHEVNKRRTFL	SCEL	26	O95171
QIKKERFDRFNACFE	SMC1A	1061	Q14683
KRKAARLKFDFQAQS	SORBS3	381	O60504
RFAASNFGKERFVKL	UNC13B	846	O14795
ERSRAFNFLNEIKKR	VAMP7	71	P51809
KLNRFFSDKQRFIDE	ULK2	941	Q8IYT8
DIQQFFEEFQSKKRR	UBR7	401	Q8N806
ALLNKENKFRDRSFS	ZFP36L2	111	P47974
AKFRKQERAAAAAAA	PHOX2B	151	Q99453
QFDQVSVFKSIRKDF	ZMYM4	141	Q5VZL5
FQFPSTEQRAVREKK	TMPRSS11A	121	Q6ZMR5
SQAIKFVNRFHEERK	VPS54	666	Q9P1Q0
KSVDFHFRTDERIKQ	TPX2	256	Q9ULW0
KSLNSRFAAFIDKVR	KRT81	111	Q14533
ERAFSFRTVEAKQEK	MYO1B	321	O43795
LFQKRQRRVQKFTFE	MYOZ3	51	Q8TDC0